GlobeNewswire All Public CompaniesQwen · 实盘不做把握 1/10不做原因:不是事件
北京时间·🕒 发布 04:15:00·⟳ 抓取 04:17:05·⚡ 决策 08-27 04:19:17 +2m12s·61.8 天前
RxSight宣布管理层将于9月9日参加Wells Fargo医疗健康会议
这是一条标准的投资者关系会议参与公告（conference participation announcement），不包含任何新增事实——无新产品、无新数据、无订单、无指引变化、无监管进展。此类公告是上市公司日常IR活动的例行披露，不改变任何基本面预期，不构成可交易的催化事件。
📄 原文GlobeNewswire All Public Companies↗ 原文
RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference
ALISO VIEJO, Calif., Aug. 26, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced that management is…
不做 RxSight（RXST.US）
例行投资者会议参与公告，不含任何新增业务、财务或监管信息，不构成可交易催化。无正期望交易机会。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
RxSight宣布管理层将于9月9日参加Wells Fargo Healthcare Conference。这是完全例行的投资者关系通知，不含任何新增业务、财务或监管信息。会议参与公告不改变市场对公司盈利、产品或竞争格局的任何预期，历史上此类公告也不会引起股价异动。事件方向为中性，无正期望交易机会，结论为不做。
🔎 新鲜度:最早出现 2026-08-26 · 扩散 low · price-in 风险 low ↗
先例如何影响了这次决策
对本次决策的影响:无需先例支撑，因为事件本身不构成催化
方向:无先例——会议参与公告本身不是催化事件，历史上不存在以'公司宣布参加投资者会议'为催化驱动股价变动的有意义案例
涨幅量级:不适用
形态:不适用
工具调用 · 历史记录,结果未知(1 种)
- search_processed_events · 结果未知
原文全文
展开原文 · 1,141 字
ALISO VIEJO, Calif., Aug. 26, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced that management is scheduled to participate in the Wells Fargo Healthcare Conference on Wednesday, September 9, 2026, at 9:30 a.m. ET in Boston, Massachusetts. A live and archived webcast of the presentation will be available on the Company’s investor relations website at
https://investors.rxsight.com/
.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight
®
Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens
®
(LAL
®
/LAL+
®
, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at
www.rxsight.com
.
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com
https://investors.rxsight.com/
.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight
®
Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens
®
(LAL
®
/LAL+
®
, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at
www.rxsight.com
.
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。